Skip to main content
. 2013 Jan 26;5(1):9–25. doi: 10.4252/wjsc.v5.i1.9

Table 8.

Proteins which are upregulated in stem cells upon ciclopirox olamine treatment compared to retinoic acid treatment

RA/CPX
ESC maGSC
Actb*1 0.12 0.10
Actb1 0.14 0.15
Atp5a11 0.43 0.48
Cotl1 0.19 0.67
Ctsd 0.95 0.16
Eif3i 0.04 0.87
Eno1*1 0.13 0.03
Eno11 0.57 0.40
Etfa 0.68 0.16
Fkbp41 0.46 0.43
Gapdh1 0.35 0.59
Glo1 0.31 0.66
Glod4 0.85 0.36
Hsp90aa1 0.28 0.38
Hsp90aa1 0.43 0.13
Hsp90ab1 0.41 0.26
Hspa5*1 0.17 0.13
Hspa9*1 0.50 0.28
Hspb1*1 0.29 0.04
Hspb1*1 0.20 0.42
Hspb11 0.82 0.50
Hspd11 0.49 0.74
Hspd11 0.42 0.33
Itpa 0.21 0.08
Mat2a1 0.41 0.14
Npm11 0.28 0.18
Nup62 0.57 0.26
Pgls1 0.40 0.68
Pkm21 0.22 0.25
Pkm21 0.29 0.86
Prdx6 0.46 0.94
Ruvbl11 0.64 0.42
S100a11*1 2 0.17
Sfrs11 0.70 0.30
Trim281 0.44 0.08
Trim281 0.42 0.44
Trim281 0.33 0.28
Tuba1b*1 0.42 0.65
Tubb51 0.42 0.54
Tubb51 0.43 0.58
Vdac1*1 0.17 0.09
1

The proteins are referred to in the text and following tables;

2

The protein was not identified in embryonic stem cells. Proteins, which are assigned an asterisk, were upregulated upon ciclopirox olamine (CPX) treatment compared to control and concurrently downregulated upon retinoic acid (RA) treatment compared to control. ESC: Embryonic stem cell; maGSC: Multipotent adult germline stem cell.